ArticleHepatitis monthly2013

Cost-effectiveness analysis of adding low dose ribavirin to peginterferon alfa-2a for treatment of chronic hepatitis C infected thalassemia major patients in iran.

Alireza Mehrazmay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.